Literature DB >> 6305965

Effects of glycosidase treatment on the physicochemical properties and biological activity of human interferon-gamma.

H C Kelker, Y K Yip, P Anderson, J Vilcek.   

Abstract

Highly purified human interferon (IFN)-gamma was treated with a preparation of mixed glycosidases in order to evaluate the effect of carbohydrate depletion on its biological activity, isoelectric point, and molecular size. Glycosidase treatment did not reduce the antiviral activity of IFN-gamma in cultures of human fibroblasts and in bat lung cells. No antiviral activity was observed before or after treatment with glycosidases in pig, mink, bovine, murine, and monkey cells. The degree of neutralization of IFN-gamma activity with specific antibody was also not significantly affected by glycosidase treatment. Several components of IFN-gamma activity were resolved by nonequilibrium pH gradient electrophoresis, with major peaks of activity at pI 8.5 and 8.7. Glycosidase treatment of IFN-gamma resulted in a reduced charge heterogeneity and a higher pI of 9.3. 125I-labeled IFN-gamma was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis into two bands with molecular weights of 25,000 and 20,000. Glycosidase treatment reduced the apparent molecular weight of these bands to 18,500 and 16,000, respectively. The results suggest that both the Mr = 25,000 and 20,000 bands, thought to be monomeric forms of IFN-gamma, are glycosylated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Autoregulation of collagenase production by a protein synthesized and secreted by synovial fibroblasts: cellular mechanism for control of collagen degradation.

Authors:  C E Brinckerhoff; M C Benoit; W J Culp
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients.

Authors:  H Yasui; K Takai; R Yoshida; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Source of heterogeneity in secreted interferon-gamma. A study on products of translation in vitro.

Authors:  N J Bulleid; E Curling; R B Freedman; N Jenkins
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

4.  Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.

Authors:  E M Curling; P M Hayter; A J Baines; A T Bull; K Gull; P G Strange; N Jenkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells.

Authors:  P Moonen; J J Mermod; J F Ernst; M Hirschi; J F DeLamarter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Increasing affinity of interferon-γ receptor 1 to interferon-γ by computer-aided design.

Authors:  Pavel Mikulecký; Jiří Cerný; Lada Biedermannová; Hana Petroková; Milan Kuchař; Jiří Vondrášek; Petr Malý; Peter Šebo; Bohdan Schneider
Journal:  Biomed Res Int       Date:  2013-10-02       Impact factor: 3.411

Review 7.  The effects of interferon-gamma on the central nervous system.

Authors:  B Popko; J G Corbin; K D Baerwald; J Dupree; A M Garcia
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.